million
human
chronic
infect
hepat
c
viru
hcv
worldwid
chronic
hcv
infect
major
biomed
problem
caus
liver
inflamm
fibrosi
lead
sever
liver
diseas
cirrhosi
hepatocellular
carcinoma
vaccin
hcv
although
bloodscreen
test
prophylact
measur
reduc
dissemin
pathogen
number
newli
acquir
infect
still
occur
associ
risk
behavior
unknown
origin
howev
chronic
hcv
infect
success
erad
chronic
infect
individu
specif
directact
antivir
daa
combin
therapi
virtual
treat
patient
sinc
specif
treatment
place
recent
suffici
clinic
data
longterm
benefit
treatment
reliev
sever
advanc
liver
diseas
hcv
hepaciviru
flavivirida
posit
sens
singlestrand
rna
genom
encod
singl
open
read
frame
orf
flank
untransl
region
utr
essenti
viral
polyprotein
translat
viral
genom
replic
hcv
orf
co
posttransl
process
cellular
viral
proteas
produc
ten
major
protein
function
classifi
replic
modul
includ
minim
viral
compon
rna
replicas
assembl
modul
compris
major
structur
compon
envelop
hcv
virion
capsid
protein
core
envelop
glycoprotein
complex
form
heterodim
well
polypeptid
structur
compon
virion
contribut
infecti
particl
assembl
concert
action
viral
replicas
hcv
util
key
aspect
cellular
lipid
metabol
essenti
everi
aspect
viru
replic
cycl
strongli
interfer
host
cell
lipid
homeostasi
fact
chronic
hcv
patient
display
high
rate
liver
steatosi
sever
invers
correl
serum
liver
derivedlipoprotein
thu
although
host
immun
respons
remain
major
compon
hcv
pathogenesi
direct
interfer
hcv
infect
hepatocyt
lipid
metabol
may
contribut
overal
diseas
progress
one
salient
manifest
hcv
interfer
lipid
metabol
cellular
level
format
distinct
membran
web
hcvreplic
cell
within
structur
hcv
rna
replic
thought
occur
doublemembran
vesicl
dmv
emerg
endoplasm
reticulum
hcv
replicas
format
requir
viral
replicas
compon
also
recruit
subvers
differ
key
cellular
factor
cooper
provid
optim
membran
microenviron
assembl
hcv
replicas
complex
sens
hcv
replicas
complex
locat
characterist
detergentresist
membran
drm
cofraction
receptor
endoplasm
reticulum
er
microdomain
contain
viral
replicas
enrich
cholesterol
probabl
direct
involv
cellular
protein
involv
nonvesicular
cholesterol
transport
assembl
progeni
virion
thought
occur
interphas
er
lipid
droplet
ld
hcv
virion
assembl
secret
process
strongli
depend
host
factor
involv
biogenesi
triacylglycerol
tag
rich
lipoprotein
thu
hcv
infect
requir
de
novo
biosynthesi
phospholipid
like
phosphatidylcholin
pc
order
gener
membran
rna
replicas
compart
tag
biosynthesi
ensur
progeni
virion
product
togeth
fact
pc
tag
biosynthesi
alter
hcv
infect
suggest
import
role
glycerophospholipid
metabol
hcv
infect
lipin
key
player
glycerophospholipid
metabol
catalyz
phosphat
remov
phosphatid
acid
pa
produc
diacylglycerol
dag
precursor
tag
also
precursor
pc
phosphatidylethanolamin
pe
biosynthesi
mammalian
cell
lipin
may
also
transloc
nucleu
directli
interact
promot
dnabind
transcript
factor
stimul
repress
transcript
lipogen
gene
two
conserv
motif
requir
phosphatid
acid
phosphatas
pap
catalyt
activ
dxdxt
transcript
regul
lxxil
respect
substrat
specif
restrict
pa
characterist
togeth
lack
integr
membran
domain
depend
catalyt
activ
differenti
lipin
mammalian
pap
bestcharacter
member
famili
discov
consequ
genet
analysi
mous
strain
display
fatti
liver
dystrophi
phenotyp
fld
mice
interestingli
delet
liver
fld
mice
result
accumul
protein
second
member
famili
predominantli
express
liver
maintain
normal
cellular
pap
activ
compens
aspect
glycerolipid
metabol
convers
knockout
mice
display
increas
protein
express
compar
wild
type
wt
litterm
suggest
similar
homeostat
compensatori
mechan
maintain
liver
pap
activ
thu
coordin
lipid
homeostasi
liver
individu
delet
toler
mice
doubl
knockout
mice
embryon
lethal
despit
appar
function
redund
emerg
key
player
ethanolinduc
steatosi
singl
nucleotid
polymorph
associ
sever
liver
damag
fibrosi
progress
pediatr
human
patient
histolog
nonalcohol
fatti
liver
diseas
nafld
suggest
liver
dysfunct
may
contribut
steatosisrel
liver
pathogenesi
studi
focus
attent
analysi
previous
publish
transcriptom
profil
dataset
reveal
gene
consist
regul
mrna
level
hcv
infect
silenc
experi
indic
hcv
infect
effici
strongli
depend
express
use
differ
cell
cultur
model
infect
identifi
limit
role
pap
activ
gener
hcv
replicas
complex
defect
replicas
assembl
lead
strong
inhibit
hcv
propag
cell
anoth
strand
rna
viru
indic
specif
role
hcv
infect
given
relev
lipid
metabol
steatogen
potenti
set
independ
verifi
data
publish
differenti
transcriptom
profil
studi
suggest
hcv
infect
may
alter
mrna
abund
cell
cultur
specif
statist
signific
mrna
induct
fig
observ
cell
singl
cycl
infect
experi
multipl
infect
moi
cell
cultureadapt
genotyp
hcv
variant
peak
infect
hour
postinfect
compar
mockinfect
cell
fig
mrna
induct
prevent
infect
cell
treat
sofosbuvir
fig
hcv
rna
polymeras
inhibitor
reduc
viral
rna
accumul
two
order
magnitud
fig
indic
activ
hcv
replic
requir
induc
mrna
accumul
mrna
shown
upregul
mechan
involv
induct
reactiv
oxygen
speci
ro
treatment
cell
rosscaveng
molecul
nacetylcystein
nac
capabl
prevent
mrna
induct
glucos
depriv
treatment
given
transcript
activ
subset
lipogen
gene
hcv
infect
also
prevent
addit
antioxid
sought
determin
mrna
induct
hcv
infect
mediat
ro
product
therefor
dampen
nac
treatment
mrna
induct
prevent
presenc
antioxid
fig
despit
compar
hcv
rna
accumul
mocktreat
nactreat
hcvinfect
cell
fig
suggest
viru
replicationinduc
ro
product
requir
induc
mrna
accumul
westernblot
analysi
confirm
observ
transcript
chang
lead
correl
protein
accumul
fig
reinforc
notion
acut
hcv
infect
alter
express
order
determin
subcellular
local
alter
hcv
infect
perform
confoc
microscopi
studi
control
hcvinfect
cell
stain
observ
cytoplasm
punctat
structur
control
hcvinfect
cell
studi
signal
coloc
viral
antigen
perform
doubl
stain
antibodi
doublestrand
rna
dsrna
replicas
subunit
none
viral
antigen
strictli
coloc
fig
howev
coeffici
indic
major
overlap
small
fraction
fig
contrast
signal
overlap
viral
protein
fig
result
indic
major
rearrang
observ
hcv
infect
minor
fraction
ns
protein
coloc
studi
play
role
hcv
infect
cell
gener
transduc
human
hepatoma
cell
lentivir
vector
express
shrna
target
mrna
control
vector
express
irrelev
shrna
express
silenc
verifi
westernblot
typic
day
posttransduct
fig
partial
profound
reduct
accumul
observ
transduct
specif
shrna
compar
control
fig
expect
express
invers
correl
shrnaexpress
cell
fig
viabil
lipindefici
cell
determin
mtt
assay
compar
control
cell
fig
result
illustr
shrnaexpress
cell
respond
homeostat
function
compens
partial
pronounc
loss
fig
control
cell
infect
genotyp
moi
studi
viral
spread
determin
extracellular
infect
titer
differ
time
post
infect
fig
show
limit
propag
viru
cell
statist
signific
reduct
two
three
order
magnitud
viral
titer
control
cell
line
day
postinfect
result
indic
requir
effici
hcv
propag
homeostat
accumul
fig
suffici
support
effici
hcv
infect
sinc
import
differ
interact
differ
hcv
genotyp
cellular
lipid
metabol
previous
describ
set
determin
observ
made
viru
genotyp
extens
hcv
genotyp
perform
low
multipl
infect
moi
genotyp
tncc
viru
strain
cell
line
suscept
infect
recombin
viru
first
verifi
also
display
signific
reduct
genotyp
infect
effici
silenc
fig
order
determin
tncc
infect
effici
intracellular
hcv
rna
accumul
determin
hour
postinocul
control
cell
viral
rna
detect
condit
reflect
abil
genotyp
infect
replic
viral
rna
differ
cell
line
treatment
control
cell
hcv
polymeras
inhibitor
reduc
viral
rna
content
two
order
magnitud
fig
silenc
consist
significantli
reduc
tncc
replic
approxim
cell
line
fig
indic
also
limit
genotyp
hcv
infect
determin
specif
observ
ident
control
cultur
inocul
moi
human
alphacoronaviru
bear
gfp
report
gene
inocul
control
cell
viru
result
compar
progeni
viru
product
determin
infect
titrat
cell
supernat
hour
postinfect
fig
result
suggest
rate
limit
infect
express
particularli
limit
hcv
determin
aspect
hcv
replic
cycl
limit
silenc
singl
cycl
infect
experi
conduct
inocul
control
cell
cultur
moi
genotyp
viru
infect
effici
measur
titrat
progeni
viru
infect
present
supernat
infect
cell
intracellular
hcv
rna
accumul
hour
postinfect
infect
cell
result
signific
reduct
progeni
infecti
viru
product
cell
compar
titer
observ
supernat
control
cell
fig
reinforc
notion
silenc
interfer
hcv
infect
reduc
viru
product
like
due
parallel
reduct
intracellular
hcv
rna
level
observ
cell
compar
control
cell
line
fig
reduct
observ
time
point
except
hour
indic
size
inoculum
initi
viru
adsorpt
compar
among
differ
cell
line
fig
thu
silenc
suppress
hcv
infect
interf
step
hcv
lifecycl
preced
intracellular
hcv
rna
accumul
next
set
determin
silenc
impact
persist
hcv
infect
verifi
also
limit
late
aspect
viru
lifecycl
persist
infect
cell
continu
replic
viral
rna
express
viral
antigen
secret
infecti
virion
thu
valuabl
system
measur
steadyst
hcv
rna
replic
well
infecti
particl
assembl
secret
persist
infect
cultur
transduc
lentivir
vector
describ
produc
persist
infect
cell
fig
analysi
extracellular
infect
titer
reveal
infect
titer
control
cell
compar
except
margin
reduct
express
cell
indic
silenc
strongli
interfer
infecti
viru
product
fig
intracellular
hcv
rna
level
cell
compar
control
cell
fig
indic
express
rate
limit
hcv
rna
replic
infect
establish
taken
togeth
result
shown
indic
limit
earli
step
hcv
infect
lead
viral
rna
accumul
independ
verif
hypothesi
limit
earli
aspect
hcv
infect
use
singl
cycl
surrog
infect
model
base
product
hcv
virion
bear
defect
report
genom
encapsid
transcomplement
hcvtcp
hcvtcp
capabl
produc
abort
singlecycl
infect
effici
proport
luciferas
activ
found
target
cell
expect
result
shown
fig
infect
cell
hcvtcp
result
reduct
report
luciferas
activ
cell
determin
hour
postinfect
proport
degre
silenc
cell
fig
result
underscor
role
play
earli
step
hcv
infect
indic
either
viral
entri
step
lead
effici
hcv
rna
replic
impair
cell
mrna
altern
splice
human
liver
produc
isoform
may
differ
catalyt
activ
subcellular
local
gene
express
regul
determin
rel
contribut
isoform
hcv
infect
isoformspecif
shrna
gener
use
transduc
cell
describ
shrna
reduc
total
protein
shrna
reduc
total
express
fig
infect
control
isoformdefici
cell
hcvtcp
reveal
silenc
result
strong
reduct
hcv
infect
silenc
result
milder
signific
reduct
hcv
infect
effici
fig
result
indic
isoform
alpha
beta
limit
hcv
infect
suggest
total
amount
present
cell
determin
hcv
infect
effici
taken
togeth
result
obtain
four
differ
shrna
indic
total
express
level
strongli
correl
hcvtcp
infect
effici
fig
underscor
role
host
protein
earli
aspect
hcv
infect
reduc
hcv
rna
accumul
singl
cycl
infect
fig
well
reduc
hcvtcp
infect
fig
may
due
defect
entri
incom
virion
hcv
retrovir
vector
bear
luciferas
gene
hcvpp
use
measur
viral
entri
constitut
sound
model
studi
viral
adsorpt
receptormedi
intern
fusion
endosom
assess
specif
observ
parallel
cultur
inocul
vsvg
pseudotyp
retrovir
vector
vsvpp
control
cell
line
infect
hcvpp
genotyp
strain
vsvpp
posit
control
inhibit
hcv
entri
use
hydroxyzin
effici
block
hcv
infect
interf
viral
entri
expect
hydroxyzin
select
inhibit
hcvpp
infect
shown
reduc
luciferas
level
hour
postinocul
hcvppinfect
cell
fig
interestingli
cell
fulli
suscept
hcvpp
vsvpp
infect
compar
luciferas
activ
level
found
cell
line
hour
postinocul
fig
result
indic
rate
limit
receptor
bind
particl
intern
endosom
fusion
step
recapitul
model
base
data
present
thu
far
hypothes
limit
step
hcv
lifecycl
downstream
hcv
entri
lead
hcv
rna
accumul
verifi
hypothesi
silenc
caus
strong
reduct
initi
hcv
rna
accumul
interf
step
downstream
viral
entri
bypass
step
viral
replic
cycl
transfect
subgenom
hcv
rna
replicon
bear
report
luciferas
gene
control
cell
first
evalu
hcvire
driven
primari
translat
incom
genom
transfect
replicationdefici
mutant
replicon
bear
inactiv
mutat
catalyt
site
rna
polymeras
luciferas
activ
measur
hour
posttransfect
reduc
cell
line
indic
transfect
effici
hcv
iresdepend
primari
translat
significantli
affect
silenc
fig
signific
increas
renilla
luciferas
activ
observ
cell
transfect
replicon
fig
plasmid
express
renilla
luciferas
minim
rna
polymeras
ii
promot
fig
suggest
increas
luciferas
activ
observ
cell
relat
hcv
hcv
rna
replic
evalu
measur
accumul
report
luciferas
gene
hour
posttransfect
replic
compet
hcv
subgenom
replicon
experiment
condit
luciferas
accumul
hour
also
repres
hcv
iresdriven
primari
translat
input
rna
report
luciferas
activ
hour
depend
effect
hcv
rna
replic
contrast
primari
translat
hcv
rna
replic
infer
luciferas
activ
hour
strongli
reduc
cell
cell
fig
indic
initi
hcv
replic
depend
normal
express
reduct
due
nonspecif
defect
luciferas
express
cotransfect
plasmid
express
renilla
luciferas
lead
compar
luciferas
accumul
cell
line
discard
possibl
death
transfect
cell
spuriou
effect
respons
reduc
luciferas
activ
accumul
fig
similar
experi
conduct
cell
host
factor
shown
limit
primari
hcv
translat
studi
confirm
partial
silenc
fig
significantli
interf
primari
translat
fig
correl
hcv
rna
replic
effici
expect
affect
hcv
rna
replic
fig
overal
data
indic
hcv
rna
replic
initi
effici
cell
blockad
occur
step
downstream
translat
incom
hcv
genom
order
determin
known
function
ascrib
requir
hcv
infect
test
abil
restor
hcv
infect
suscept
silencingresist
wildtyp
wt
mutant
version
bear
mutat
catalyt
site
respons
phosphatas
activ
dxdxt
mutant
lxxil
motif
inact
transcript
activ
well
phosphatas
activ
control
cell
transfect
wt
beta
cdna
well
dxdxt
lxxil
mutant
compar
overexpress
level
wt
mutant
protein
obtain
cell
line
although
overexpress
level
consist
higher
cell
fig
cell
subsequ
inocul
hcv
moi
rel
infect
effici
calcul
determin
extracellular
infect
titer
hour
postinfect
overexpress
wt
significantli
alter
suscept
hcv
infect
control
cell
although
observ
small
consist
reduct
extracellular
infect
titer
overexpress
wt
mutant
construct
fig
contrast
control
cell
wt
overexpress
cell
consist
increas
infect
titer
compar
mocktransfect
cell
fig
clear
contrast
reduct
observ
control
cell
fig
overexpress
mutant
cell
fig
order
take
account
diverg
behavior
control
cell
calcul
rel
infect
effici
ratio
infect
titer
found
cell
control
cell
fig
ratio
subsequ
normal
found
mocktransfect
cell
order
averag
data
differ
experi
fig
use
rel
infect
effici
readout
set
experi
could
clearli
observ
statist
signific
increas
rel
infect
suscept
cell
overexpress
wt
cdna
compar
mocktransfect
cell
cell
express
similar
higher
level
mutant
fig
suggest
wt
modestli
though
significantli
rescu
hcv
infect
phosphatas
dxdxt
transcript
coactiv
lxxil
mutant
fig
result
suggest
transcript
coactiv
capac
suffici
support
hcv
infect
phosphatas
activ
essenti
howev
given
lxxil
mutant
defici
transcript
coactiv
pap
activ
determin
transcript
coactiv
also
requir
support
hcv
infect
data
describ
suggest
role
phosphatas
activ
step
hcv
replic
cycl
translat
viral
genom
format
function
replicas
complex
data
regard
primari
translat
infer
surrog
model
translat
base
report
luciferas
gene
fig
address
inde
viral
polyprotein
properli
process
insert
detergentresist
microdomain
form
characterist
membran
ultrastructur
bear
viral
replicas
use
replicationindepend
surrog
model
polyprotein
express
system
base
vector
encod
portion
viral
polyprotein
correspond
replicas
transcript
control
polymeras
translat
control
encephalomyocard
viru
emcv
ire
replicationindepend
polyprotein
overexpress
system
enabl
assess
polyprotein
process
well
studi
format
virusderiv
membran
structur
control
cell
infect
recombin
vaccinia
viru
express
rna
polymeras
subsequ
transfect
plasmid
enabl
viral
replicas
express
sixteen
hour
posttransfect
cell
process
westernblot
use
accumul
compar
control
cell
underscor
notion
limit
polyprotein
translat
process
fig
similarli
express
subcellular
distribut
similar
cell
line
fig
result
suggest
major
differ
accumul
viral
protein
cell
step
downstream
affect
cell
transmiss
electron
microscopi
tem
ultrathin
cell
section
cell
express
hcv
replicas
compon
show
expect
accumul
mixtur
characterist
doublemembran
vesicl
dmv
well
multipl
membran
vesicl
mmv
fig
found
mocktransfect
cell
fig
report
previou
studi
use
similar
system
individu
vesicl
diamet
display
heterogen
size
distribut
predomin
popul
distribut
nm
median
nm
averag
sd
nm
n
larger
vesicl
less
predomin
fig
fig
size
distribut
compat
observ
similar
replicationdefici
system
hcv
infect
treatment
cell
nm
daclatasvir
dctv
result
strong
reduct
number
vesicl
per
section
area
fig
without
significantli
alter
size
distribut
remain
vesicl
fig
report
berger
et
al
similarli
diamet
distribut
vesicl
found
cell
compar
control
cell
fig
howev
hcvinduc
structur
significantli
less
abund
hour
posttransfect
cell
control
cell
fig
reduc
abund
illustr
signific
reduct
fraction
cell
display
vesicular
structur
cell
cultur
fig
despit
compar
transfect
effici
viral
protein
express
level
indic
may
requir
critic
step
lead
format
hcvinduc
vesicular
compart
valid
tem
result
independ
set
establish
biochem
assay
evalu
replicationindepend
replicas
complex
format
one
characterist
hcv
replicas
complex
locat
detergentresist
membran
drm
sens
ns
protein
associ
replicas
complex
cosedi
drm
marker
receptor
lowdens
fraction
isopycn
gradient
ultracentrifug
experi
control
cell
infect
subsequ
transfect
limit
dose
plasmid
parallel
sampl
treat
dctv
nm
sixteen
hour
posttransfect
cell
lysat
gener
subject
equilibrium
ultracentrifug
sucros
gradient
gradient
fraction
collect
subject
westernblot
analysi
determin
impact
silenc
actin
sediment
profil
fig
show
previous
shown
replicon
cell
detect
drm
fraction
fraction
determin
presenc
fraction
fraction
fig
although
experiment
system
unlik
viral
infect
cosedi
togeth
solubil
protein
shown
actin
fraction
fig
drmassoci
reduc
dctvtreat
cell
total
express
remain
unchang
fig
four
independ
experi
perform
relativedrm
associ
normal
found
solubil
fraction
calcul
experiment
condit
fig
cell
display
consist
statist
signific
reduct
drmassoci
total
abund
fig
similar
observ
control
cell
presenc
dctv
fig
shcontroldctv
consist
tem
data
fig
notion
drm
fraction
may
reflect
abund
replicas
complex
form
cell
reduct
due
overal
reduct
cellular
drm
abund
cell
cell
display
similar
distribut
pattern
control
cell
fig
overal
tem
data
drm
floatat
assay
strongli
suggest
rate
limit
gener
replicas
complex
fulli
process
polyprotein
subunit
hepat
c
viru
replic
cycl
tightli
link
host
cell
lipid
metabol
interfer
cellular
lipid
homeostasi
contribut
viral
pathogenesi
one
evid
consequ
interfer
high
preval
liver
steatosi
among
chronic
infect
patient
clinic
manifest
infect
link
among
other
chronic
er
stress
mitochondri
dysfunct
metabolit
deplet
induc
hcv
infect
result
activ
persist
homeostat
adapt
cellular
lipid
metabol
permit
cell
surviv
cost
pathogen
metabol
alter
among
differ
regulatori
network
shown
stimul
hcv
infect
srebp
also
shown
regul
transcript
mrna
thu
like
stimul
one
sever
regulatori
network
hcv
infect
result
mrna
transcript
activ
observ
fig
studi
importantli
prevent
mrna
accumul
nac
fig
significantli
interfer
hcv
rna
replic
fig
suggest
enhanc
mrna
accumul
requir
effici
hcv
infect
favor
hypothesi
ro
induc
hcv
protein
accumul
activ
particip
induct
treatment
antioxid
nac
prevent
mrna
accumul
similar
shown
srebpregul
gene
hcv
infect
accumul
mrna
hcv
infect
result
concomit
protein
accumul
fig
howev
posttransl
mechan
phosphoryl
acetyl
sumoyl
regul
protein
stabil
membran
associ
well
subcellular
local
thu
influenc
activ
paphosphatas
transcript
coactiv
henc
difficult
predict
implic
protein
accumul
hcv
infect
thu
futur
studi
interfer
hcv
infect
cellular
function
requir
determin
role
hcvrelat
pathogenesi
particularli
contribut
steatosi
data
present
studi
provid
evid
rate
limit
hcv
infect
earli
step
infect
lead
format
membran
hcv
replicas
complex
downstream
viral
polyprotein
express
process
provid
evid
reduc
accumul
viral
rna
singl
cycl
infect
experi
fig
reminisc
faulti
initi
viral
replic
suggest
reduc
replic
transfect
subgenom
replicon
cell
fig
data
obtain
replicationindepend
polyprotein
express
model
suggest
gener
membran
compart
contain
function
replicas
complex
sever
limit
cell
suggest
signific
reduct
fraction
cell
structur
could
visual
tem
fig
hypothesi
support
signific
reduct
drmassoci
ns
protein
cell
fig
may
reflect
limit
associ
viral
replicas
subunit
cholesterol
sphingolipidrich
membran
cell
four
differ
shrna
target
mrna
decreas
suscept
hcv
infect
proport
abil
reduc
total
protein
accumul
fig
result
togeth
cdna
rescu
experi
fig
strongli
reduc
possibl
observ
rnaiassoci
offtarget
phenomena
interestingli
homeostat
accumul
protein
cell
fig
suffici
compens
loss
support
effici
hcv
infect
notion
despit
capabl
mutual
compens
basic
liver
function
play
nonredund
function
liver
previous
propos
tightli
regul
mani
differ
level
activ
accommod
pap
activ
respons
differ
physiolog
situat
fast
insulin
signal
compel
evid
indic
cooper
maintain
liver
lipid
homeostasi
two
protein
differ
mani
aspect
instanc
transcript
induc
also
induc
amplifi
transcript
network
wherea
sumoyl
sumoyl
regul
nuclear
local
function
wherea
sumoyl
could
demonstr
despit
presenc
canon
sumoyl
motif
primari
sequenc
enzymat
activ
block
mammalian
target
rapamycin
mtor
depend
phosphoryl
respons
differ
metabol
stimuli
wherea
constitut
activ
even
phosphoryl
thu
consid
constitut
phosphatid
acid
phosphatas
lower
specif
activ
addit
differenti
regulatori
network
shown
vitro
pap
activ
purifi
differenti
influenc
composit
substrat
liposom
lipiddeterg
micel
well
ph
assay
perform
differenti
lipid
substrat
recognit
may
reminisc
differ
preferenti
associ
membran
differ
subcellular
compart
fig
differ
suggest
may
share
common
featur
function
interchang
particularli
case
hcv
infect
data
support
notion
silenc
strong
impact
hcv
infect
without
affect
basic
cellular
function
fig
significantli
interf
infect
unrel
viru
fig
despit
great
effort
differ
overexpress
system
function
rescu
function
wt
cdna
overexpress
cell
lead
small
consist
rescu
viru
infect
effici
observ
overexpress
wt
fig
given
multipl
transcript
posttranscript
posttransl
regul
level
exist
express
conceiv
fraction
overexpress
fulli
compet
sustain
hcv
infect
moreov
high
overexpress
level
could
achiev
cell
fig
underscor
notion
intracellular
level
tightli
regul
host
nevertheless
overexpress
mutant
lack
phosphatas
activ
dxdxt
mutant
inact
transcript
coactiv
lxxil
capabl
enhanc
hcv
infect
cell
compar
wt
fig
data
reveal
phosphatas
activ
requir
support
hcv
infect
suggest
transcript
coactiv
may
import
function
suffici
support
hcv
replic
lipin
import
enzym
main
pathway
de
novo
phospholipid
biosynthesi
provid
dag
deriv
pathway
produc
pc
pe
kennedi
pathway
product
membran
replicas
compart
like
requir
de
novo
synthesi
pc
andor
pe
major
compon
biolog
membran
depend
dag
biosynthesi
fact
local
pc
biosynthesi
requir
effici
replic
rna
virus
certain
pc
speci
accumul
hcvinfect
cell
although
increas
accumul
may
suffici
compens
silenc
wholecel
level
possibl
acut
local
demand
de
novo
synthes
phospholipid
requir
defin
suborganellar
compart
earli
step
hcv
infect
shorten
alter
avail
differ
membran
compon
demand
may
satisfi
given
differenti
regul
subcellular
local
two
protein
fig
remark
delet
yeast
lipin
homolog
cerevisa
pomb
gene
result
deregul
prolifer
er
nuclear
envelop
membran
concomit
enhanc
rna
viru
replic
membran
alter
elev
total
phospholipid
content
observ
yeast
ascrib
transcript
activ
altern
phospholipid
biosynthet
program
due
pa
accumul
data
mammalian
cell
compat
shortag
phospholipid
product
may
basi
reduc
abund
viral
membran
structur
fig
opposit
outcom
infect
may
deriv
fact
yeast
use
mainli
pa
pap
substrat
precursor
pc
biosynthesi
mammal
mainli
use
dag
pap
product
precursor
pc
biosynthesi
kennedi
pathway
moreov
contrast
yeast
lower
eukaryot
express
one
lipin
gene
three
differ
lipin
gene
coordin
glycerolipid
homeostasi
mammal
thu
interf
express
one
member
famili
may
suffici
observ
effect
observ
delet
transcript
posttransl
homeostat
compens
place
mammal
particularli
liver
tissu
sens
delet
either
mous
model
result
rel
balanc
liver
phospholipid
content
simultan
delet
lipin
embryon
lethal
accordingli
minor
alter
er
membran
signific
alter
total
pc
level
report
mous
liver
given
fact
fulli
capabl
replic
cell
fig
unlik
gener
disrupt
de
novo
phospholipid
biosynthesi
occur
cell
particularli
sinc
infect
also
induc
profound
er
membran
rearrang
requir
replic
structur
similar
dmv
observ
hcv
infect
thu
favor
hypothesi
subcellular
pool
glycerophospholipid
manag
cell
silenc
perturb
local
level
pa
dag
limit
local
avail
precursor
structur
compon
virusinduc
membran
altern
defici
may
alter
local
amount
import
signal
molecul
particular
substrat
pa
product
dag
deregul
local
pa
dag
pool
may
caus
import
alter
host
cell
metabolit
potent
chemic
messeng
regul
differ
aspect
cellular
homeostasi
regard
pa
convers
dag
lipin
shown
yeast
homolog
phosphatas
activ
critic
transform
local
pool
pa
dag
er
membran
facilit
membran
fusion
event
mediat
snare
complex
mammalian
phosphatas
activ
also
critic
transform
local
pool
pa
accumul
surfac
mitochondria
promot
mitochondri
fission
surfac
endolysosom
facilit
autophagi
thu
probabl
member
lipin
famili
modul
differ
aspect
intracellular
membran
signal
given
function
host
factor
known
involv
function
hcv
replicas
biogenesi
like
vapa
vapb
osbp
indirectli
regul
local
padag
pool
tempt
propos
silenc
interfer
function
one
sever
yet
uncharacter
cellular
factor
contrast
report
host
factor
requir
hcv
replicas
complex
format
find
evid
protein
reloc
hcv
infect
fig
thu
determin
precis
mechan
regul
hcv
replicas
format
challeng
associ
differ
cell
membran
transient
highli
regul
posttransl
modif
moreov
known
cellular
function
may
compens
lipin
particularli
liver
nevertheless
data
clearli
indic
particip
earli
stage
hcv
replic
aforement
homeostat
compens
lipin
regard
cellular
metabol
may
constitut
advantag
consid
host
target
antihcv
therapi
hcv
antivir
compound
sofosbuvir
daclatasvir
obtain
boc
scienc
ny
usa
selleckchem
texa
usa
medchem
express
new
jersey
usa
respect
dissolv
dmso
obtain
stock
solut
nacetylcystein
nac
puromycin
obtain
sigmaaldrich
missouri
usa
dissolv
water
final
concentr
mgml
respect
hydroxyzin
pamoat
purchas
sigmaaldrich
missouri
usa
dissolv
dmso
final
mm
concentr
genotyp
strain
adapt
viru
genotyp
tncc
viru
describ
elsewher
tncc
plasmid
kindli
provid
dr
jen
bukh
huidovr
hospit
copenhagen
denmark
recombin
virus
gener
electropor
vitro
transcrib
rna
describ
previous
use
clone
cell
viru
cell
tncc
supernat
contain
infecti
viru
use
inocul
naiv
clone
cell
low
multipl
infect
moi
ffucel
prepar
work
viru
stock
tncc
infect
supernat
electropor
cell
directli
use
lentivir
vector
shrna
express
produc
cotransfect
plasmid
pmdlrre
prsvrev
gift
didier
tronoaddgen
plasmid
togeth
genom
plasmid
mission
plkopuro
sigmaaldrich
cell
select
shrna
target
sequenc
cgagagaaagtggttgacata
cctcagacagaaatgcagttt
cactcccagtccttccggttc
cctgttccatccttcggaaag
plasmid
encod
shrna
nontarget
shrna
shcontrol
well
shrna
target
hcv
ire
shhcv
previous
describ
lentivir
vector
plasmid
encod
cdna
purchas
genecopeia
cat
nbr
gener
beta
isoform
exon
sequenc
insert
use
mutagenesi
kit
neb
similarli
silent
mutat
introduc
target
sequenc
obtain
wt
protein
express
cdna
resist
silenc
mutat
conserv
motif
dxdxt
didgt
eidgt
lxxil
lghil
lghff
also
introduc
cdna
use
kit
base
previous
describ
mutat
sequenc
entir
cdna
determin
sanger
sequenc
use
assess
introduct
desir
mutat
recombin
human
coronaviru
kindli
provid
dr
volker
thiel
univers
bern
switzerland
viru
propag
infect
moi
cell
supernat
collect
differ
time
point
titrat
endpoint
dilut
immunofluoresc
microscopi
lentivir
vector
express
control
shrna
use
inocul
cell
twentyfour
hour
later
cell
subject
select
puromycin
assess
lowest
lentiviru
dose
capabl
confer
puromycin
resist
cell
popul
select
cell
popul
subsequ
cultur
presenc
puromycin
silenc
ascertain
westernblot
use
antibodi
typic
day
post
lentivir
transduct
time
experi
perform
absenc
puromycin
execut
experi
shown
studi
express
assess
westernblot
cell
viabil
determin
thiazolyl
blue
tetrazolium
blue
mtt
formazan
format
assay
control
cell
line
cellswel
plate
onto
plate
inocul
viru
moi
ffucel
sampl
cell
supernat
collect
hour
postinfect
multipl
cycl
infect
experi
moi
sampl
supernat
collect
day
postinocul
cell
split
multipl
cycl
infect
experi
day
maintain
cultur
subconflu
extracellular
infect
titer
determin
endpoint
dilut
infect
foci
count
previous
describ
intracellular
hcv
rna
determin
revers
transcript
quantit
pcr
rtqpcr
previous
describ
total
protein
sampl
prepar
laemmli
buffer
separ
use
polyacrylamid
denatur
gel
electrophoresi
sdspage
protein
subsequ
transfer
onto
pvdf
membran
incub
milk
lipin
bsa
one
hour
room
temperatur
rt
primari
antibodi
clone
santa
cruz
santa
cruz
clone
biofront
betaactin
abcam
tubulin
clone
sigmaaldrich
dilut
incub
hour
four
hour
lipin
rt
membran
subsequ
wash
minut
three
time
horseradish
peroxidaseconjug
secondari
antibodi
incub
hour
room
temperatur
subsequ
wash
three
time
minut
room
temperatur
protein
band
detect
use
enhanc
chemoluminesc
reaction
exposur
photograph
film
specif
band
quantit
use
imagej
softwar
nonsatur
scan
film
cell
grown
glass
coverslip
infect
high
multipl
moi
viru
fortyeight
hour
post
infect
cell
fix
minut
rt
formaldehyd
solut
pb
wash
twice
pb
incub
incub
buffer
bsa
triton
pb
hour
antibodi
dilut
incub
buffer
rabbit
antibodi
cell
signalingleiden
netherland
rabbit
antibodi
santa
cruz
mous
antidsrna
clone
scicon
clone
biofront
clone
biofront
primari
antibodi
incub
cell
hour
hour
experi
time
cell
wash
pb
subsequ
incub
dilut
goat
antimous
conjug
alexa
alexa
invitrogencarlsbad
ca
nuclei
stain
dapi
life
technolog
secondari
antibodi
incub
use
recommend
cell
wash
pb
mount
glass
slide
prolong
invitrogencarlsbad
ca
confoc
microscopi
perform
leica
tc
laser
scan
system
leica
microsystem
imag
pixel
eight
bit
gray
scale
depth
acquir
sequenti
everi
na
immers
oil
len
employ
la
af
v
softwar
leica
microsystem
coloc
index
calcul
use
jacop
plugin
imag
j
minimum
region
interest
roi
imag
process
use
imagej
median
pixel
obtain
differ
channel
illustr
analysi
color
level
bright
contrast
manipul
illustr
use
technic
biolog
control
refer
total
rna
extract
perform
use
gtc
extract
method
purifi
rna
ng
subject
rtqpcr
use
random
hexam
revers
transcript
kit
appli
biosystem
quantit
pcr
perform
use
reaction
buffer
appli
biosystem
specif
oligonucleotid
previous
describ
standard
curv
prepar
serial
dilut
known
copi
number
correspond
amplicon
clone
plasmid
vector
control
cell
inocul
tncc
viru
moi
due
rel
low
propag
level
tncc
viru
experiment
setup
parallel
cultur
infect
treat
determin
level
nonrepl
background
hcv
rna
cell
incub
hour
time
sampl
cell
collect
determin
intracellular
hcv
rna
level
rtqpcr
establish
persist
infect
cell
cultur
cell
inocul
moi
hcv
strain
previous
describ
cell
cultur
maintain
subconflu
two
week
time
infect
rate
reach
nearli
cell
assess
immunofluoresc
microscopi
point
cell
split
transduc
correspond
lentivir
vector
order
gener
cell
cultur
well
control
cell
line
silenc
verifi
westernblot
typic
day
posttransduct
cell
split
sampl
cell
supernat
collect
hour
later
determin
intracellular
hcv
rna
level
rtqpcr
extracellular
infect
titer
endpoint
dilut
immunofluoresc
microscopi
infecti
spreaddefici
hcv
particl
produc
transcomplement
hcvtcp
previous
describ
briefli
clone
cell
express
region
lentivir
transduct
electropor
subgenom
dicistron
replicon
bear
firefli
luciferas
gene
reagent
kindli
provid
dr
ralf
bartenschlag
u
heidelberg
supernat
contain
hcvtcp
collect
hour
postelectropor
pool
assay
viral
infect
hcvtcp
infect
effici
determin
inocul
cell
electropor
supernat
measur
luciferas
activ
hour
postinfect
use
commerci
avail
kit
promega
retrovir
particl
product
pseudotyp
differ
viral
envelop
previous
describ
materi
kindli
provid
dr
f
l
cosset
inserm
lyon
control
lipindefici
cell
line
inocul
hcvpp
vsvpp
incub
hour
time
total
cell
lysat
assay
luciferas
activ
use
commerci
avail
kit
promega
select
hcv
entri
inhibitor
hydroxyzin
pamoat
hdx
sigmaaldrich
missouri
usa
use
posit
control
inhibit
plasmid
contain
sequenc
correspond
subgenom
replicon
bear
firefli
luciferas
report
gene
kindli
provid
dr
ralf
bartenschlag
u
heidelberg
digest
restrict
enzym
mlui
linear
plasmid
transcrib
vitro
use
commerci
kit
megascript
ambionpaisley
uk
result
product
digest
dnase
precipit
licl
pellet
rna
wash
ethanol
resuspend
nucleasefre
water
vitro
transcrib
rna
transfect
differ
cell
line
togeth
plasmid
express
renilla
luciferas
minim
promot
prlnull
clontechcalifornia
usa
use
lipofectamin
recommend
life
technolog
california
usa
firefli
renilla
luciferas
activ
measur
sampl
use
commerci
kit
dual
luciferas
assay
system
promegawisconsin
usa
differ
time
posttransfect
cell
gener
lentivir
transduct
shrna
day
posttransduct
control
cell
popul
x
well
transfect
suspens
use
lipofectamin
plasmid
well
express
wt
isoform
cdna
dxdxt
lxxil
motif
mutant
transfect
cell
cultur
incub
hour
subsequ
inocul
moi
viru
infect
effici
determin
measur
extracellular
infect
titer
hour
postinfect
parallel
cultur
use
determin
rel
wt
mutant
protein
express
effici
westernblot
infect
titer
measur
describ
rel
impact
cdna
express
estim
determin
ratio
infect
found
cell
control
cell
transfect
plasmid
order
averag
experi
differ
raw
infect
effici
experi
referenc
ratio
mocktransfect
cell
control
cell
inocul
moi
hour
cell
wash
twice
warm
pb
replenish
fc
extracellular
infect
titer
determin
hour
postinfect
endpoint
dilut
fluoresc
microscopi
cell
cell
inocul
moi
recombin
vaccinia
viru
express
phage
rna
polymeras
two
hour
later
cell
transfect
plasmid
kindli
provid
dr
lohmann
u
heidelberg
lipofectamin
thermofishermassachusset
usa
follow
recommend
term
total
dna
per
well
typic
per
dish
x
cellswel
recommend
lipofectamin
dna
ratio
transfect
cell
cultur
presenc
dna
replic
inhibitor
cytosin
arac
sigmaaldrich
hour
prevent
replic
indic
media
also
supplement
daclatasvir
dctv
total
cell
extract
use
determin
viral
protein
accumul
westernblot
use
antibodi
clone
biofront
abcam
load
control
ultrastructur
electron
microscopi
studi
control
cell
express
polyprotein
see
cultur
glass
coverslip
fix
situ
polyprotein
express
mixtur
paraformaldehyd
taab
glutaraldehyd
taab
room
temperatur
postfix
osmium
tetroxid
pb
min
treat
aqueou
uranyl
acet
min
dehydr
increas
quantiti
ethanol
embed
epoxi
resin
taab
ultrathin
section
cut
parallel
monolay
transfer
formvarco
em
buttonhol
grid
stain
aqueou
uranyl
acet
min
lead
citrat
min
section
visual
jeol
jem
exii
electron
microscop
oper
kv
quantit
hcvinduc
structur
perform
follow
quantit
differ
total
vesicl
abund
tem
section
visual
inspect
microscop
presenceabs
vesicular
structur
number
posit
cell
total
number
cell
insert
x
conting
tabl
determin
statist
signific
differ
control
cell
use
twotail
exact
test
twotail
chi
squar
test
addit
determin
frequenc
hcvinduc
vesicl
dctvtreat
control
cell
divid
number
structur
per
inspect
area
calcul
averag
sd
frequenc
found
differ
imag
diamet
individu
vesicl
determin
manual
use
sizecalibr
imag
imag
j
softwar
control
cell
x
cell
infect
viru
moi
transfect
limit
dose
plasmid
typic
ng
well
higher
plasmid
dose
may
difficult
observ
report
differ
cell
lyse
ad
tne
trishcl
ph
nacl
mm
edta
mm
buffer
contain
triton
proteas
inhibitor
complet
roch
basel
sw
lysat
incub
minut
ice
clear
centrifug
rpm
clear
supernat
mix
sucros
tne
solut
mixtur
appli
top
sucrosetn
cushion
overlaid
sucrosetn
complet
discontinu
gradient
gradient
centrifug
hour
x
g
fourteen
fraction
collect
top
analyz
sdspage
westernblot
use
antibodi
clone
biofront
santacruz
epitom
beta
actin
describ
previous
signal
quantit
use
imagej
softwar
fraction
drmassoci
determin
ratio
signal
fraction
total
signal
gradient
